ginsenoside rh2 has been researched along with catechin in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (catechin) | Trials (catechin) | Recent Studies (post-2010) (catechin) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 11,544 | 477 | 6,612 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | catechin (IC50) |
|---|---|---|---|
| Arginase | Leishmania amazonensis | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, T; Wang, S; Zhang, M | 1 |
1 other study(ies) available for ginsenoside rh2 and catechin
| Article | Year |
|---|---|
The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Neoplasm Proteins; Pyrazines; Urinary Bladder Neoplasms | 2016 |